Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04068753
Title Niraparib in Combination With TSR-042 in Patients With Recurrent or Progressive Cervix Cancer (STAR)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Oklahoma

cervical cancer


Dostarlimab-gxly + Niraparib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.